Seelaus Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,161
Closed -$497K 218
2020
Q4
$497K Sell
2,161
-3,206
-60% -$739K 0.36% 88
2020
Q3
$1.36M Sell
5,367
-1,086
-17% -$269K 1.1% 27
2020
Q2
$1.52M Sell
6,453
-262
-4% -$59.8K 1.39% 19
2020
Q1
$1.36M Sell
6,715
-33
-0.5% -$7.21K 1.61% 14
2019
Q4
$1.63M Sell
6,748
-520
-7% -$115K 1.31% 20
2019
Q3
$1.41M Sell
7,268
-332
-4% -$63.7K 1.23% 23
2019
Q2
$1.4M Buy
7,600
+3,747
+97% +$671K 1.27% 22
2019
Q1
$732K Sell
3,853
-2,697
-41% -$515K 0.68% 52
2018
Q4
$1.27M Buy
+6,550
New +$1.28M 1.37% 20

Other funds holding AMGN

Seelaus Asset Management's AMGN Position: Q1 2021 in Review

Seelaus Asset Management sold out of Amgen (AMGN) in Q1 2021, closing a stake of 2,161 shares — an estimated $497K sold.

Seelaus Asset Management first reported a position in AMGN in Q4 2018 and held it in 9 quarters. The position peaked at $1.63M in Q4 2019. 2,219 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.

  • Seelaus Asset Management reported no remaining Amgen position as of Q1 2021 after selling out during the quarter.
  • Seelaus Asset Management sold 2,161 Amgen shares in Q1 2021, an estimated $497K.
  • Seelaus Asset Management first reported a position in Amgen in Q4 2018 and held it in 9 quarters.
  • Seelaus Asset Management's Amgen position peaked at $1.63M in Q4 2019.
  • 2,219 funds tracked by Wall St. Rank held Amgen as of Q1 2021.

Based on Seelaus Asset Management's 13F filing for Q1 2021, filed 26 Apr 2021.